Recombinant Proteins
Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (10)
- (1,878)
- (108)
- (1)
- (1)
- (46)
- (8)
- (15)
- (1)
- (331)
- (1)
- (1)
- (28,502)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (6)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (5)
- (3)
- (3)
- (2)
- (1)
- (4)
- (1)
- (29,183)
- (202)
- (16)
- (15)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (218)
- (4)
- (867)
- (1)
- (14)
- (1)
- (53)
- (2)
- (2)
- (1)
- (42)
- (9)
- (46)
- (27)
- (2)
- (52)
- (138)
- (143)
- (13)
- (12)
- (2)
- (8)
- (2)
- (153)
- (4)
- (3)
- (3)
- (2)
- (2)
- (5)
- (14)
- (30,024)
- (4,517)
- (2)
- (4)
For Use With (Application)
- (1)
- (2,851)
- (1)
- (28,533)
- (1)
- (30)
- (65)
- (4,609)
- (24)
- (1)
- (8)
- (2)
- (8)
- (21,580)
- (2)
- (2)
- (2)
- (1)
- (1)
- (8)
- (59)
- (2)
- (2)
- (45)
- (4)
- (2)
- (6)
- (3)
- (1)
- (1)
- (5)
- (1)
- (1)
- (1)
- (248)
- (22,929)
- (1)
- (16)
- (4)
- (1)
- (1)
- (28)
- (4)
- (51,455)
- (23)
- (2)
- (4)
- (32)
- (2)
- (685)
- (4)
- (3)
- (216)
- (1)
- (1)
- (129)
- (5,194)
- (1,567)
- (3)
- (1)
- (72)
- (7)
- (3)
- (4)
- (1)
- (19,642)
- (24)
- (31)
- (19)
- (1)
- (3)
- (451)
- (16)
- (1)
- (3)
- (125)
- (150)
- (98)
- (259)
- (15)
- (4)
- (1)
- (1,598)
- (257)
- (239)
- (4)
- (1)
- (19)
- (37)
- (11)
- (4)
- (1)
- (2)
- (10)
- (10)
- (2)
- (9)
- (1)
- (13)
- (2)
- (2)
- (1)
- (2)
- (4,211)
- (4)
- (1)
- (309)
- (1)
- (4)
- (3)
- (1)
- (1)
- (47,860)
- (198)
- (817)
- (654)
- (1)
- (197)
- (62)
- (4)
- (6)
- (22)
- (1)
- (3)
- (6)
- (1)
- (197)
- (1)
- (8,248)
- (4)
- (4)
- (1)
- (13)
- (2)
- (4)
- (14)
- (5)
- (414)
- (1)
- (1)
- (1)
- (50,963)
Recombinant
- (12)
- (67,635)
- (17)
Form
- (3)
- (21)
- (49,910)
- (7,287)
- (3,666)
- (136)
- (17)
- (3,413)
Conjugate
- (2)
- (1)
- (66)
- (1)
- (4)
- (2)
- (11)
- (64)
- (1)
- (4)
- (4)
- (1)
- (384)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (4)
- (2)
- (103)
- (12)
- (2)
- (3)
- (2)
- (2)
- (1)
- (14)
- (665)
- (1)
- (2)
- (3)
- (48)
- (42,303)
- (1)
- (2)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
1
–
15
of
77,921
results
1
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-1 |
| Molecular Weight (g/mol) | 25 kDa |
| Gene Symbol | Tgfb1 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
| Storage Requirements | -20°C |
| Expression System | HEK293 cells |
| For Use With (Application) | Functional Assay |
| Source | HEK293 cells |
| Name | Human TGF-beta 1 |
| Accession Number | P01137 |
| Regulatory Status | RUO |
| Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
| Biological Activity | The ED50 was determined by TGF-beta1's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Gene ID (Entrez) | 7040 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
2
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene Symbol | IL1B |
| Sequence | APVRSLNCTL RDSQQKSLVM SGPYELKALH LQGQDMEQQV VFSMSFVQGE ESNDKIPVAL GLKEKNLYLS CVLKDDKPTL QLESVDPKNY PKKKMEKRFV FNKIEINNKL EFESAQFPNW YISTSQAENM PVFLGGTKGG QDITDFTMQF VSS |
| Storage Requirements | -20°C |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human IL-1 beta |
| Accession Number | P01584 |
| Regulatory Status | RUO |
| Gene ID (Entrez) | 3553 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
3
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Endotoxin Concentration | <0.1 ng/ μg |
| Expression System | E. coli |
| For Use With (Application) | Control,ELISA,Functional Assay,Immunohistochemistry,Western Blot |
| Name | Human EGF |
| Purification Method | Sequential Chromatography |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco™ |
4
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-10 |
| Molecular Weight (g/mol) | 18.6 kDa |
| Gene Symbol | IL10 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MSPGQGTQSE NSCTHFPGNL PNMLRDLRDA FSRVKTFFQM KDQLDNLLLK ESLLEDFKGY LGCQALSEMI QFYLEEVMPQ AENQDPDIKA HVNSLGENLK TLRLRLRRCH RFLPCENKSK AVEQVKNAFN KLQEKGIYKA MSEFDIFINY IEAYMTMKIR N |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human IL-10 |
| Accession Number | P22301 |
| Regulatory Status | RUO |
| Gene Alias | CSIF; cytokine; Cytokine synthesis inhibitory factor; GVHDS; H-IL-10; il 10; IL10; IL-10; IL-10 precursor; IL10A; IL10X; ILN; Interleukin; interleukin 10; Interleukin10; interleukin-10; MGC126450; MGC126451; RP11-262N9.1; T-cell growth inhibitory factor; TGIF |
| Biological Activity | Determined by the dose-dependent co-stimulation (with human IL-4) of MC/9 cells. The ED50 was found to be ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Gene ID (Entrez) | 3586 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
5
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IFN gamma |
| Molecular Weight (g/mol) | 16.8 kDa |
| Gene Symbol | IFNG |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human IFN-gamma |
| Accession Number | P01579 |
| Regulatory Status | RUO |
| Gene Alias | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN ?; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFN?; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon ?; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferon?; M-IFN-g; R-IFN-g |
| Biological Activity | The ED50 determined by a cytotoxicity assay using HT-29 cells is = 0.05 ng/ml, corresponding to a specific activity of = 2 x 10^7 units/mg |
| Gene ID (Entrez) | 3458 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
6
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17.2 kDa |
| Gene Symbol | FGF2 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human FGF-basic (FGF-2/bFGF) (154 aa) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Biological Activity | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 2247 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
7
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-4 |
| Molecular Weight (g/mol) | 15.1 kDa |
| Gene Symbol | Il4 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MHKCDITLQE IIKTLNSLTE QKTLCTELTV TDIFAASKNT TEKETFCRAA TVLRQFYSHH EKDTRCLGAT AQQFHRHKQL IRFLKRLDRN LWGLAGLNSC PVKEANQSTL ENFLERLKTI MREKYSKCSS |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human IL-4 |
| Accession Number | P05112 |
| Regulatory Status | RUO |
| Gene Alias | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4 delta2; interleukin 4 variant IL-4 delta3; interleukin 4 variant IL-4 int2A; interleukin 4 variant IL-4 int3A; interleukin 4 variant IL-4 int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of human TF-1 cells is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
| Gene ID (Entrez) | 3565 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
8
Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Source | E. coli |
| Name | Human EGF, Animal-Free |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Biological Activity | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1950 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
9
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | GDNF |
| Molecular Weight (g/mol) | 30.4 kDa |
| Gene Symbol | GDNF |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MSPDKQMAVL PRRERNRQAA AANPENSRGK GRRGQRGKNR GCVLTAIHLN VTDLGLGYET KEELIFRYCS GSCDAAETTY DKILKNLSRN RRLVSDKVGQ ACCRPIAFDD DLSFLDDNLV YHILRKHSAK RCGCI |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human GDNF |
| Accession Number | P39905 |
| Regulatory Status | RUO |
| Gene Alias | AI385739; Astrocyte-derived trophic factor; ATF; ATF1; ATF2; Gdnf; glial cell derived neurotrophic factor; glial cell line derived neurotrophic factor; Glial cell line derived neutrophic factor; glial cell line-derived neurotrophic factor; gndf; HFB1-GDNF; hGDNF; H-GDNF; HSCR3; mGDNF; neurotrophic factor |
| Biological Activity | Determined by a cell proliferation assay using SH-SY5Y cells. The expected ED50 for this effect is 1.0-10.0 ng/ml |
| Gene ID (Entrez) | 2668 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
10
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TNF alpha |
| Molecular Weight (g/mol) | 17.4 kDa |
| Gene Symbol | Tnf |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human TNF-alpha |
| Accession Number | P01375 |
| Regulatory Status | RUO |
| Gene Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF a; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFa; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1 F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Biological Activity | The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Gene ID (Entrez) | 7124 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
11
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | M-CSF |
| Molecular Weight (g/mol) | 36.8 kDa |
| Gene Symbol | Csf1 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MEEVSEYCSH MIGSGHLQSL QRLIDSQMET SCQITFEFVD QEQLKDPVCY LKKAFLLVQD IMEDTMRFRD NTPNAIAIVQ LQELSLRLKS CFTKDYEEHD KACVRTFYET PLQLLEKVKN VFNETKNLLD KDWNIFSKNC NNSFAECSSQ GHERQSEGS |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human M-CSF |
| Accession Number | P09603 |
| Regulatory Status | RUO |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Biological Activity | The ED50 was determined by the dose-dependent stimulation of the proliferation of murine M-NSF-60 cells ≤ 1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 1435 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
12
Invitrogen™ Albumin from Bovine Serum (BSA), Alexa Fluor™ 488 conjugate
Bright and photostable conjugate exceptionally suited for applications in which well-defined molecular weight tracers are needed
13
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6 kDa |
| Endotoxin Level | Very Low |
| Endotoxin Concentration | <0.1 ng/ μg |
| Expression System | E. coli |
| For Use With (Application) | Control,ELISA,Functional Assay,Immunohistochemistry,Western Blot |
| Name | Mouse EGF |
| Purification Method | Sequential Chromatography |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Full Length, Recombinant, Ligand |
| Biological Activity | ED50 < 5 ng/mL; determined by the dose-dependent proliferation of BALB/c 3T3 cells. |
| Formulation | protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Mouse |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | -20°C |
| Gene Symbol | EGF |
| Sequence | NSYPGCPSSY DGYCLNGGVC MHIESLDSYT CNCVIGYSGD RCQTRDLRWW ELR |
| Storage Requirements | -20°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01132 |
| Gene ID (Entrez) | 13645 |
| Product Line | Gibco™ |
14
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | PDGF-AA |
| Molecular Weight (g/mol) | 28.5 kDa |
| Gene Symbol | Pdgfa |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | SIEEAVPAV CKTRTVIYEI PRSQVDPTSA NFLIWPPCVE VKRCTGCCNT SSVKCQPSRV HHRSVKVAKV EYVRKKPKLK EVQVRLEEHL ECACATTSLN PDYREEDTGR PRESGKKRKR KRLKPT |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human PDGF-AA |
| Accession Number | P04085 |
| Regulatory Status | RUO |
| Gene Alias | H-PDGF-AA; PDGF A-chain; PDGF subunit A; PDGF1; PDGF-1; Pdgfa; PDGF-A; PDGFACP; platelet derived growth factor subunit A; platelet derived growth factor, alpha; Platelet-derived growth factor A chain; platelet-derived growth factor A-chain; platelet-derived growth factor alpha chain; platelet-derived growth factor alpha polypeptide; Platelet-derived growth factor subunit A; Rpa1 |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of Balb/c 3T3 cells. The expected ED50 for this effect is 1.0-3.0 ng/ml |
| Gene ID (Entrez) | 5154 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
15
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | GM-CSF |
| Molecular Weight (g/mol) | 14.6 kDa |
| Gene Symbol | CSF2 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MAPARSPSPS TQPWEHVNAI QEARRLLNLS RDTAAEMNET VEVISEMFDL QEPTCLQTRL ELYKQGLRGS LTKLKGPLTM MASHYKQHCP PTPETSCATQ IITFESFKEN LKDFLLVIPF DCWEPVQE |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human GM-CSF |
| Accession Number | P04141 |
| Regulatory Status | RUO |
| Gene Alias | colony stimulating factor 2; colony stimulating factor 2 (granulocyte-macrophage); colony-stimulating factor; CSF; CSF2; Csfgm; cytokine; GMCSF; Gm-CSf; granulocyte macrophage colony stimulating factor; granulocyte macrophage-colony stimulating factor; granulocyte-macrophage colony stimulating factor 2; granulocyte-macrophage colony-stimulating factor; MGC131935; MGC138897; MGC151255; MGC151257; MGI-IGM; M-GM-CSF; molgramostin; put. GM-CSF; sargramostim |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1437 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |